z-logo
open-access-imgOpen Access
FKBPL Is a Critical Antiangiogenic Regulator of Developmental and Pathological Angiogenesis
Author(s) -
Anita Yakkundi,
R. Avery Bennett,
Ivette Hernández-Negrete,
JeanMarie Delalande,
Mary L. Hanna,
Oksana Lyubomska,
Ken Arthur,
Amy Short,
Hayley D. McKeen,
Laura L. Nelson,
Cian M. McCrudden,
Ross McNally,
Lana McClements,
Helen O. McCarthy,
Alan J. Burns,
Roy Bicknell,
Adrien Kissenpfennig,
Tracy Robson
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.114.304539
Subject(s) - angiogenesis , zebrafish , biology , microbiology and biotechnology , neovascularization , gene knockdown , sprouting angiogenesis , regulator , ex vivo , in vivo , cancer research , cell culture , biochemistry , genetics , gene
The antitumor effects of FK506-binding protein like (FKBPL) and its extracellular role in angiogenesis are well characterized; however, its role in physiological/developmental angiogenesis and the effect of FKBPL ablation has not been evaluated. This is important as effects of some angiogenic proteins are dosage dependent. Here we evaluate the regulation of FKBPL secretion under angiogenic stimuli, as well as the effect of FKBPL ablation in angiogenesis using mouse and zebrafish models.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom